首页> 中文期刊> 《肾脏病(英文)》 >Prevalence of Cardiovascular Risk Factors in Chronic Hemodialysis Patients at the University Hospital Center of Point G in Bamako, Mali

Prevalence of Cardiovascular Risk Factors in Chronic Hemodialysis Patients at the University Hospital Center of Point G in Bamako, Mali

         

摘要

Introduction: A cardiovascular risk factor (FDRCV) is defined as a physiological, pathological or environmental attribute or characteristic that results in an increased likelihood of developing cardiovascular disease in the individual in whom it is detected. The objective of this study was to determine the prevalence of cardiovascular risk factors in hemodialysis patients on hemodialysis at the University Hospital of Point G. Patients and Methods: This was a cross-sectional descriptive study with prospective data collection from March 3, 2009 to March 5, 2010 (13 months). Included were all patients with end-stage renal disease (ESRD) receiving chronic hemodialysis in the Nephrology and Hemodialysis Department of the University Hospital of Point G during the study period. Results: Eighty-eight patients were enrolled. The M/F sex ratio was 1.26. The mean age was 41.32 years with extremes of 17 and 81 years. The classic cardiovascular risk factors in order of frequency were: hypertension (90.9%), sedentary lifestyle (71.6%), male sex (54.5%), age ≥ 55 years (21.6%), obesity (13.6%), diabetes (8%), tobacco (8%), alcohol (3.4%). Cardiovascular risk factors related to CKD were: anemia (98.9%), phosphocalcic disorders (85.2%), arteriovenous fistula (AVF) (80%), lipid abnormalities (36.5%), hydrosodium inflation (29.5%). Predominant cardiovascular complications were hypertensive heart disease (62.5%), acute pulmonary oedema (APO) (50%), rhythm disorders (23.9%), coronary insufficiency (18.2%). The mortality rate was 17%. Conclusion: Cardiovascular risk factors are frequent in chronic hemodialysis. They contribute to the excess mortality of these patients. Adequate management of these risk factors can slow down serious cardiovascular complications and reduce the risk of mortality in this fragile population.

著录项

  • 来源
    《肾脏病(英文)》 |2020年第2期|P.125-134|共10页
  • 作者单位

    Nephrology and Haemodialysis Department of the CHU of Point G Bamako MaliFaculty of Medicine University of Bamako Bamako Mali;

    Faculty of Medicine University of Bamako Bamako MaliNephrology Unit of the Fousseyni DAOU Hospital of Kayes Kayes Mali;

    Nephrology Unit of Mali GAVARDO Hospital Bamako Mali;

    Faculty of Medicine University of Bamako Bamako MaliCardiology Department of Mali Hospital Bamako Mali;

    Nephrology and Haemodialysis Department of the CHU of Point G Bamako MaliFaculty of Medicine University of Bamako Bamako Mali;

    Nephrology and Haemodialysis Department of the CHU of Point G Bamako MaliFaculty of Medicine University of Bamako Bamako Mali;

    Nephrology and Haemodialysis Department of the CHU of Point G Bamako Mali;

    Nephrology and Haemodialysis Department of the CHU of Point G Bamako Mali;

    Nephrology and Haemodialysis Department of the CHU of Point G Bamako Mali;

    Nephrology and Haemodialysis Department of the CHU of Point G Bamako Mali;

    Nephrology and Haemodialysis Department of the CHU of Point G Bamako Mali;

    Faculty of Medicine University of Bamako Bamako MaliInternal Medicine Service at the University Hospital Center of Point G Bamako Mali;

    Nephrology and Haemodialysis Department of the CHU of Point G Bamako MaliFaculty of Medicine University of Bamako Bamako Mali;

    Nephrology and Haemodialysis Department of the CHU of Point G Bamako MaliFaculty of Medicine University of Bamako Bamako Mali;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 泌尿科学(泌尿生殖系疾病);
  • 关键词

    Cardiovascular Risk Factors; Haemodialysis; Mali;

    机译:心血管危险因素;血液透析;马里;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号